• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

141,667
80,641
53,703
50,049
37,095

COUNTRY

135,610
8,836
6,575
5,228
4,287

CATEGORIES

  • 822
  • 3,869
  • 340
  • 329
  • 2,702
  • 12,203
  • 787
  • 1,769
  • 24
  • 227,552
  • 67,630

PRICE

917,162
957,110
965,319
1,015,245

PUBLISHED

27,026
128,340
228,136
1,015,245

PRODUCT TYPE

386,018
329,548
295,181
4,435
50
8
4
1

Company Reports

(1,015,245 Products)

Research and Markets' company reports offer in-depth analysis and detailed information on thousands of the world's leading companies. Reports take a variety of formats, offering details such as contact information, business summaries, performance analysis, product information, officer and employee information, sector and industry classifications, business and earnings announcement summaries, financial statistics and ratios.

So if your organisation is looking to invest, form a new partnership, enter a new market, stay one step ahead of the opposition, or simply add to its business intelligence with the latest, precisely detailed market research publications, then start your search now.
Show Less
Read more

PRODUCT TITLE
Q4 2012 Earnings Call - Omega Healthcare Investors, Inc., - Earnings Transcript Q4 2012 Earnings Call - Omega Healthcare Investors, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2012 Earnings Call - Omega Healthcare Investors, Inc., - Earnings Transcript

Q4 2012 Earnings Call - Omega Healthcare Investors, Inc., - Earnings Transcript Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - London - Norsk Hydro ASA, - Earnings Transcript Q4 2012 Earnings Call - London - Norsk Hydro ASA, - Earnings Transcript - Product Thumbnail Image

Q4 2012 Earnings Call - London - Norsk Hydro ASA, - Earnings Transcript

Q4 2012 Earnings Call - London - Norsk Hydro ASA, - Earnings Transcript Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - Huntsman Corp. - Earnings Transcript Q4 2012 Earnings Call - Huntsman Corp. - Earnings Transcript - Product Thumbnail Image

Q4 2012 Earnings Call - Huntsman Corp. - Earnings Transcript

Q4 2012 Earnings Call - Huntsman Corp. - Earnings Transcript Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - Huntsman Corp. - Call Street Report Q4 2012 Earnings Call - Huntsman Corp. - Call Street Report - Product Thumbnail Image

Q4 2012 Earnings Call - Huntsman Corp. - Call Street Report

Q4 2012 Earnings Call - Huntsman Corp. - Call Street Report Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - Albany Molecular Research, Inc., - Call Street Report Q4 2012 Earnings Call - Albany Molecular Research, Inc., - Call Street Report - Product Thumbnail Image

Q4 2012 Earnings Call - Albany Molecular Research, Inc., - Call Street Report

Q4 2012 Earnings Call - Albany Molecular Research, Inc., - Call Street Report Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - Ryman Hospitality Properties, Inc., - Earnings Transcript Q4 2012 Earnings Call - Ryman Hospitality Properties, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2012 Earnings Call - Ryman Hospitality Properties, Inc., - Earnings Transcript

Q4 2012 Earnings Call - Ryman Hospitality Properties, Inc., - Earnings Transcript Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - Norwegian Cruise Line Holdings Ltd. - Earnings Transcript Q4 2012 Earnings Call - Norwegian Cruise Line Holdings Ltd. - Earnings Transcript - Product Thumbnail Image

Q4 2012 Earnings Call - Norwegian Cruise Line Holdings Ltd. - Earnings Transcript

Q4 2012 Earnings Call - Norwegian Cruise Line Holdings Ltd. - Earnings Transcript Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - Spartan Motors, Inc. - Earnings Transcript Q4 2012 Earnings Call - Spartan Motors, Inc. - Earnings Transcript - Product Thumbnail Image

Q4 2012 Earnings Call - Spartan Motors, Inc. - Earnings Transcript

Q4 2012 Earnings Call - Spartan Motors, Inc. - Earnings Transcript Tuesday, February 12, 2013 03:00

February 2013
BioTechnology Industry Organization CEO & Investor Conference - Gilead Sciences, Inc., - Earnings Transcript BioTechnology Industry Organization CEO & Investor Conference - Gilead Sciences, Inc., - Earnings Transcript - Product Thumbnail Image

BioTechnology Industry Organization CEO & Investor Conference - Gilead Sciences, Inc., - Earnings Transcript

BioTechnology Industry Organization CEO & Investor Conference - Gilead Sciences, Inc., - Earnings Transcript Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - Albany Molecular Research, Inc., - Earnings Transcript Q4 2012 Earnings Call - Albany Molecular Research, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2012 Earnings Call - Albany Molecular Research, Inc., - Earnings Transcript

Q4 2012 Earnings Call - Albany Molecular Research, Inc., - Earnings Transcript Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - Diebold, Inc., - Call Street Report Q4 2012 Earnings Call - Diebold, Inc., - Call Street Report - Product Thumbnail Image

Q4 2012 Earnings Call - Diebold, Inc., - Call Street Report

Q4 2012 Earnings Call - Diebold, Inc., - Call Street Report Tuesday, February 12, 2013 03:00

February 2013
Q4 2012 Earnings Call - Vanda Pharmaceuticals, Inc., - Earnings Transcript Q4 2012 Earnings Call - Vanda Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2012 Earnings Call - Vanda Pharmaceuticals, Inc., - Earnings Transcript

Q4 2012 Earnings Call - Vanda Pharmaceuticals, Inc., - Earnings Transcript Tuesday, February 12, 2013 03:00

February 2013
Research Update: AmWINS Group LLC 'B' Rating Affirmed, New Debt Rated 'B' (Recovery Rating '4'); Outlook Is Stable Feb 13 Research Update: AmWINS Group LLC 'B' Rating Affirmed, New Debt Rated 'B' (Recovery Rating '4'); Outlook Is Stable Feb 13 - Product Thumbnail Image

Research Update: AmWINS Group LLC 'B' Rating Affirmed, New Debt Rated 'B' (Recovery Rating '4'); Outlook Is Stable Feb 13

Abstract AmWINS Group LLC is seeking to issue a new $715 million first-lien term loan to refinance its existing first- and second-lien term loans. We are affirming our 'B' counterparty credit rating...

February 2013
AmWINS Group LLC 'B' Rating Affirmed, New Debt Rated 'B' (Recovery Rating '4'); Outlook Is Stable Feb 13 AmWINS Group LLC 'B' Rating Affirmed, New Debt Rated 'B' (Recovery Rating '4'); Outlook Is Stable Feb 13 - Product Thumbnail Image

AmWINS Group LLC 'B' Rating Affirmed, New Debt Rated 'B' (Recovery Rating '4'); Outlook Is Stable Feb 13

Abstract AmWINS Group LLC is seeking to issue a new $715 million first-lien term loan to refinance its existing first- and second-lien term loans. We are affirming our 'B' counterparty credit rating...

February 2013
Summary: District Of Columbia Housing Finance Agency; Multifamily FHA Insurance Feb 13 Summary: District Of Columbia Housing Finance Agency; Multifamily FHA Insurance Feb 13 - Product Thumbnail Image

Summary: District Of Columbia Housing Finance Agency; Multifamily FHA Insurance Feb 13

Abstract Standard & Poor's Ratings Services has affirmed its 'AA+' rating on District of Columbia Housing Finance Agency's Federal Housing Administration (FHA)-insured multifamily housing revenue bonds...

February 2013
Summary: Montgomery, Minnesota; General Obligation; Non-School State Programs Feb 13 Summary: Montgomery, Minnesota; General Obligation; Non-School State Programs Feb 13 - Product Thumbnail Image

Summary: Montgomery, Minnesota; General Obligation; Non-School State Programs Feb 13

Abstract Standard & Poor's Ratings Services has revised its outlook to positive from stable and affirmed its 'BBB' long-term rating on Montgomery, Minn.'s series 2012A general obligation (GO) refunding...

February 2013
Montgomery, MN's 2012A 'BBB' GO Bond Rating Outlook Revised To Positive On Effort To Return To Structural Balance Feb 13 Montgomery, MN's 2012A 'BBB' GO Bond Rating Outlook Revised To Positive On Effort To Return To Structural Balance Feb 13 - Product Thumbnail Image

Montgomery, MN's 2012A 'BBB' GO Bond Rating Outlook Revised To Positive On Effort To Return To Structural Balance Feb 13

Abstract CHICAGO (Standard & Poor's) Feb. 12, 2013-- Standard & Poor's Ratings Services has revised its outlook to positive from stable and affirmed its 'BBB' long-term rating on Montgomery, Minn.'s...

February 2013
Summary: Sterling, Illinois Leggett & Platt Inc.; Letter of Credit Feb 13 Summary: Sterling, Illinois Leggett & Platt Inc.; Letter of Credit Feb 13 - Product Thumbnail Image

Summary: Sterling, Illinois Leggett & Platt Inc.; Letter of Credit Feb 13

Abstract Standard & Poor's Ratings Services has confirmed its 'AA-/A-1+' ratings on Sterling, Ill.'s (Leggett & Platt Inc.) taxable variable-rate demand limited obligation tax increment revenue bonds...

February 2013
Mississippi Hospital Equipment & Facilities Authority North Mississippi Health Services; System Feb 13 Mississippi Hospital Equipment & Facilities Authority North Mississippi Health Services; System Feb 13 - Product Thumbnail Image

Mississippi Hospital Equipment & Facilities Authority North Mississippi Health Services; System Feb 13

Abstract Standard & Poor's Ratings Services has affirmed its 'AA' long-term rating on Mississippi Hospital Equipment & Facilities Authority's $71.63 million series 2010-1 revenue bonds, issued for...

February 2013
Research Update: Nielsen Holding N.V. 'BB' Rating Affirmed After Proposed Acquisition; Outlook Stable Feb 13 Research Update: Nielsen Holding N.V. 'BB' Rating Affirmed After Proposed Acquisition; Outlook Stable Feb 13 - Product Thumbnail Image

Research Update: Nielsen Holding N.V. 'BB' Rating Affirmed After Proposed Acquisition; Outlook Stable Feb 13

Abstract We have reevaluated U.S. global information and measurement company Nielsen Holding N.V.'s business and financial prospects pro forma for its proposed acquisition of Arbitron Inc. We now expect...

February 2013
Loading Indicator

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.